Changing Seroepidemiology of Hepatitis B, C, and D Virus Infections in High-Risk Populations

Journal of Medical Virology

Volumn 72, Issue 1, 2004, Pages 41-45

  Huo, Teh Ia ^a   Wu, Jaw Ching ^a   Wu, Shiow Ing ^b   Chang, An Lung ^b   Lin, Shih Ku ^c   Pan, Chun Hung ^c   Huang, Yi Hsiang ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Munic Venereal Dis Contr Inst   (Taiwan)

^c TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatitis D virus; Prevalence

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS D ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMIGRANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOMES RESEARCH; PROSTITUTION; SEROEPIDEMIOLOGY; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTITUTION; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 0344443741     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10554     Document Type: Article

References (25)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 2:1129-1133.
2. Caselmann WH, Alt M. 1996. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 24:61-66.
3. Chen DS, Lai MY, Sung JL. 1984. δ Agent infection in patients with chronic liver disease and hepatocellular carcinoma-An infrequent finding in Taiwan. Hepatology 4:502-503.
4. Chen CJ, Tseng SF, Lu CF, Lin HC, You SL, Chen CS, Hwang SJ, Hsieh SF, Hsu ST. 1992. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. J Med Virol 38:97-101.
5. Chen TZ, Wu JC, Yen FS, Shen WY, Hwang SJ, Huo TI, Lee SD. 1995. Injection with non-disposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol 46:247-251.
6. Chung DC, Ko YC, Chen CJ, Chen ER, Wu CC, Wu PS. 1989. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan. J Med Virol 28:215-218.
7. Fattovich G, Boscaro S, Noventa F, Pornaro E, Stenico D, Alberti A, Ruol A, Realdi G. 1987. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 155:931-935.
8. Govindarajan S, Lee SD, Tong MJ, Tsai YT, Lo KJ. 1984. Prevalence of delta agent among Chinese in Taiwan and Los Angeles. J Med Virol 14:33-37.
9. Hadziyannis SJ, Dourakis SP, Papaioannou C. 1993. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. In: Hadziyannis SJ, Taylor JM, Bonino F, editors. Hepatitis Delta virus: Molecular biology, pathogenesis, and clinical aspects. New York: Wiley-Liss. pp 259-266.
10. Hsu HM, Wang YF, Lo SH, Sun HC, Yip KK, Chen JS, Chuang CH, Chen DS. 1990. Hepatitis D virus infection among intravenous drug abusers in Taiwan: Analysis of risk factors and liver function tests. J Med Virol 31:76-81.
11. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. 1997. Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors. J Gastroenterol Hepatol 12:747-751.
12. Kao JH, Cen PJ, Lai MY, Chen DS. 2002. Hepatitis D virus genotypes in intravenous drug abuser in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40:3047-3049.
13. Lee SD, Wang YJ, Wu JC, Chang YT, Tsai YT, Lo KJ. 1986. Hepatitis B and hepatitis D virus infection among drug abusers in Taiwan. J Med Virol 20:247-252.
14. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KJ. 1991. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13:830-833.
15. Navascues CA, Rodriguez M, Sotorrio NG, Sala P, Linares A, Suarez A, Rodrigo L. 1995. Epidemiology of hepatitis D virus infection: Changes in the last 14 years. Am J Gastroenterol 90:1981-1984.
16. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 Years after mass hepatitis B vaccination. Ann Intern Med 135:796-800.
17. Sagnelli E, Stroffolini T, Ascione A. 1993. The epidemiology of hepatitis delta infection in Italy over the past 18 years. In: Hadziyannis SJ, Taylor JM, Bonino F, editors. Hepatitis Delta virus: Molecular biology, pathogenesis, and clinical aspects. New York: Wiley-Liss. pp 287-294.
18. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxi A, Giusti G, Piccinino F. 1997. Decrease in HDV endemicity in Italy. J Hepatol 26:20-24.
19. Tong MJ, Sun SC, Shaffer BT, Lo KJ, Peters RL. 1971. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 75:687-691.
20. Wu JC, Lee SD, Govindarajan S, Lin HC, Chou P, Wang YJ, Lee SY, Tsai YT, Lo KJ, Ting LP. 1990. Sexual transmission of hepatitis D virus infection in Taiwan. Hepatology 11:1057-1061.
21. Wu JC, Wang YJ, Hwang SJ, Chen TZ, Wang YS, Lin HC, Lee SD, Sheng WY. 1993a. Hepatitis D virus infection among prostitutes in Taiwan. J Gastroenterol Hepatol 8:334-337.
22. Wu JC, Lin HC, Jeng FS, Ma GY, Lee SD, Sheng WY. 1993b. Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 39:312-317.
23. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. 1994. Multiple virus infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: Application and limitations of the polymerase chain reaction. Hepatology 19:836-840.
24. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, Tsay SH, Lee SD. 1995a. Natural history of hepatitis D viral superinfection: Significance of viremia detected by polymerase chain reaction. Gastroenterology 108:796-802.
25. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. 1995b. Genoctyping of hepatitis D virus by restriction-fragment length-polymorphism and relation to outcome of hepatitis D. Lancet 346:939-941.